Hooman Motahari
Role not yet determined Is this you? Add your title
Also affiliated: Lincoln Medical Center (2016–2018); University of Miami (2016); University of Illinois Chicago (2014); Central Arkansas Veterans Healthcare System (2021)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Hooman Motahari's research has explored various aspects of human health, with a focus on the thyroid gland and public health implications. His work includes a systematic review and meta-analysis on the association of thyroid function with suicidal behavior, and investigations into the consequences of iodine deficiency in pregnant individuals. Motahari has also examined the discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism, and the potential for biotin supplementation to create misleading diagnoses of secondary adrenal insufficiency. His research interests extend to pain treatment for underserved older African Americans and the impact of climate change on respiratory infections. Motahari has published 12 papers, accumulating 437 citations, and holds an h-index of 7. He collaborates with several researchers at the University of Arkansas for Medical Sciences, including Soumya Thumma, Richard R. Owen, Spyridoula Maraka, and Lakshmi Menon.
Metrics
- h-index: 7
- Publications: 12
- Citations: 438
Selected Publications
-
Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial (2025)
-
THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial (2023)
-
Association of Thyroid Function with Suicidal Behavior: A Systematic Review and Meta-Analysis (2021)
-
Biotin Supplementation Creates the Misleading Diagnosis of Secondary Adrenal Insufficiency (2021)
-
A Case of Diabetic Keto Acidosis From Alpelisib (2021)
-
Most Patients with COVID-19 Are Euthyroid (2021)
-
Consequences of Severe Iodine Deficiency in Pregnancy: Evidence in Humans (2020)
Collaboration Network
Top Collaborators
- Consequences of Severe Iodine Deficiency in Pregnancy: Evidence in Humans
- Association of Thyroid Function with Suicidal Behavior: A Systematic Review and Meta-Analysis
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- Most Patients with COVID-19 Are Euthyroid
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Association of Thyroid Function with Suicidal Behavior: A Systematic Review and Meta-Analysis
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- Biotin Supplementation Creates the Misleading Diagnosis of Secondary Adrenal Insufficiency
- A Case of Diabetic Keto Acidosis From Alpelisib
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Consequences of Severe Iodine Deficiency in Pregnancy: Evidence in Humans
- Association of Thyroid Function with Suicidal Behavior: A Systematic Review and Meta-Analysis
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- Association of Thyroid Function with Suicidal Behavior: A Systematic Review and Meta-Analysis
- Biotin Supplementation Creates the Misleading Diagnosis of Secondary Adrenal Insufficiency
- A Case of Diabetic Keto Acidosis From Alpelisib
- Association of Thyroid Function with Suicidal Behavior: A Systematic Review and Meta-Analysis
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- A Case of Diabetic Keto Acidosis From Alpelisib
Similar Researchers
Based on overlapping research topics